Iovance Biotherapeutics, Inc. (IOVA)

Trade IOVA now with
8/25/2022 7:58:33 AM Iovance Biotherapeutics Initiates BLA Submission For Lifileucel In Advanced Melanoma
9/23/2021 7:47:29 AM Iovance Biotherapeutics Begins Clinical Supply Of TIL Cell Therapy Manufactured At Iovance Cell Therapy Center
6/29/2021 6:34:47 AM Iovance Biotherapeutics Announces Clinical Data For LN-145 In Non-Small Cell Lung Cancer
4/10/2018 8:45:12 AM B. Riley FBR Upgrades Iovance Biotherapeutics, Inc. (IOVA) To Buy From Neutral With $22 Price Target